Form 4: PROCEPT BioRobotics Director Taylor Harris Boosts Equity Holdings Through New Grants

PROCEPT BioRobotics Corp Director Taylor C. Harris has increased his beneficial ownership in the company through the acquisition of restricted stock units and stock options.

Summary

• Taylor C. Harris, a Director of PROCEPT BioRobotics Corp (PRCT), reported changes in his beneficial ownership of company securities.
• On June 10, 2025, Mr. Harris acquired 1,538 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
• These RSUs represent a contingent right to receive one share of Common Stock and will vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Additionally, on June 10, 2025, Mr. Harris acquired 2,771 Stock Options (Right to Buy) with an exercise price of $64.23 per share.
• These stock options also vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service, and have an expiration date of June 9, 2035.
• Following these transactions, Mr. Harris directly beneficially owns 99,176 shares of Common Stock and 2,771 Stock Options.
• He also indirectly beneficially owns 35,074 shares of Common Stock through The Harris Trust, for which he serves as trustee.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While a Form 4 is a routine disclosure, a director increasing their equity stake (even through grants) generally signals confidence in the company's future and aligns their interests with shareholders. It is not a major market-moving event but is a positive indicator of insider alignment.

Positives

• The acquisition of additional equity by a director, Taylor C. Harris, aligns his interests more closely with those of shareholders, indicating confidence in the company's future.
• The grants of Restricted Stock Units (RSUs) and Stock Options are common forms of executive and director compensation, designed to incentivize long-term commitment and performance.

Future Outlook

The acquired Restricted Stock Units and Stock Options are subject to vesting conditions, which will occur on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, contingent upon continued service.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity grant to a director. Such grants are standard practice across industries to align management and director incentives with shareholder value creation, particularly in growth-oriented sectors like medical robotics.

Related Party Transactions

• Taylor C. Harris indirectly beneficially owns 35,074 shares of Common Stock held in the name of The Harris Trust, of which he is the trustee.

Stakeholder Impact

• Shareholders: The increased equity ownership by a director can be viewed positively as it enhances alignment between management and shareholder interests, potentially leading to more shareholder-friendly decisions.
• Employees: The compensation structure for directors, including equity grants, can reflect the company's overall approach to incentivizing key personnel.

Next Steps

• The vesting of the 1,538 Restricted Stock Units and 2,771 Stock Options will occur on the earlier of the one-year anniversary of the grant date (June 10, 2026) or the date of the next annual meeting following the grant date, subject to continued service.

Key Dates

Keywords

PROCEPT BioRobotics, PRCT, Taylor C. Harris, Director, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSUs, Stock Options, Beneficial Ownership, Corporate Governance